Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Cyclophosphamide"
Narrow search
Narrow search
Year of publication
From:
To:
Subject
All
Cyclophosphamide
7
Cisplatin
3
Fluorouracil
3
Pharmacoeconomics
3
Antineoplastics
2
Cost-analysis
2
Cost-effectiveness
2
Cost-utility
2
Doxorubicin
2
Etoposide
2
Granulocyte-colony-stimulating-factors
2
Methotrexate
2
Paclitaxel
2
Taxanes
2
Advanced-breast-cancer
1
Alkylating-agents
1
Anthracyclines
1
Antimalarials
1
Antirheumatics
1
Auranofin
1
Azathioprine
1
Bone-marrow-transplant
1
Breast-cancer
1
Chemotherapy-induced-anaemia
1
Cost analysis
1
Cost effectiveness
1
Cyclosporin
1
Disease modifying antirheumatics
1
Early-breast-cancer
1
Epirubicin
1
Etanercept
1
Filgrastim
1
Gold
1
Infliximab
1
Leflunomide
1
Lenograstim
1
Melphalan
1
Mitoxantrone
1
Neutropenia
1
Ovarian cancer
1
more ...
less ...
Online availability
All
Undetermined
7
Type of publication
All
Article
7
Language
All
Undetermined
7
Author
All
Barron, Richard L.
1
Bojke, Laura
1
Chia, Victoria M.
1
Coyle, Douglas
1
Danese, Mark D.
1
Das Gupta, Roben
1
Delozier, Thierry
1
Fabbro, Michel
1
Gabriel, Sherine E.
1
Girling, David
1
Gleeson, Michelle L.
1
Griffiths, Robert I.
1
Guest, Julian F.
1
Janvier, Maud
1
Le Corroller, Anne-Gaelle
1
Legg, Jason C.
1
Limat, Samuel
1
Livartowski, Alain
1
Lyman, Gary H.
1
Madroszyk-Flandin, Anne
1
Marino, Patricia
1
Menat, Celine
1
Merrouche, Yacine
1
Moatti, Jean-Paul
1
Molinier, Laurent
1
Moreland, Larry W.
1
O'Hagan, Anthony OHagan
1
Palangie, Thao
1
Qian, Wendi
1
Radice, Davide
1
Redaelli, Alberto
1
Sculpher, Mark
1
Stephens, Richard
1
Thatcher, Nick
1
Viens, Patrice
1
Woronoff-Lemsi, Marie-Christine
1
more ...
less ...
Published in...
All
PharmacoEconomics
7
Source
All
RePEc
7
Showing
1
-
7
of
7
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer
Griffiths, Robert I.
;
Barron, Richard L.
;
Gleeson, …
- In:
PharmacoEconomics
30
(
2012
)
2
,
pp. 103-118
epirubicin);
cyclophosphamide
(C); taxane ([T]: paclitaxel or docetaxel); and fluorouracil (F). Patients were …
Persistent link: https://www.econbiz.de/10010614316
Saved in:
2
Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Co...
Bojke, Laura
;
Sculpher, Mark
;
Stephens, Richard
;
Qian, Wendi
- In:
PharmacoEconomics
24
(
2006
)
5
,
pp. 443-452
-CSF given in addition to doxorubicin,
cyclophosphamide
and etoposide (ACE) versus ACE alone in the management of SCLC. Methods …
Persistent link: https://www.econbiz.de/10005590493
Saved in:
3
Q-TWiST Analysis of
Cyclophosphamide
, Epirubicin, Fluorouracil versus
Cyclophosphamide
, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cance...
Radice, Davide
;
Redaelli, Alberto
- In:
PharmacoEconomics
23
(
2005
)
1
,
pp. 69-75
axillary node-positive breast cancer receiving either
cyclophosphamide
, epirubicin and fluorouracil (CEF) or
cyclophosphamide
…
Persistent link: https://www.econbiz.de/10005404873
Saved in:
4
From Randomised Clinical Trials to Clinical Practice: A Pragmatic Cost-Effectiveness Analysis of Paclitaxel in First-Line Therapy for Advanced Ovarian Cancer
Limat, Samuel
;
Woronoff-Lemsi, Marie-Christine
;
Menat, …
- In:
PharmacoEconomics
22
(
2004
)
10
,
pp. 633-641
cyclophosphamide
-cisplatin (CC) regimens using a pragmatic perspective based on daily clinical practice in a French university hospital …
Persistent link: https://www.econbiz.de/10005590550
Saved in:
5
Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer
Marino, Patricia
;
Le Corroller, Anne-Gaelle
;
Palangie, Thao
- In:
PharmacoEconomics
21
(
2003
)
11
,
pp. 807-818
Objective: To evaluate the potential cost savings of using sequential high dose chemotherapy (HDC), with granulocyte colony-stimulating factor (filgrastim) and stem cell support, rather than single course administration of HDC with bone marrow transplantation (BMT) or peripheral blood stem cell...
Persistent link: https://www.econbiz.de/10005590492
Saved in:
6
A Model to Estimate the Cost Benefit of an Occupational Vaccination Programme for Influenza with Influvac(R) in the UK Use of the tradename is for product identification purposes o...
Das Gupta, Roben
;
Guest, Julian F.
- In:
PharmacoEconomics
20
(
2002
)
7
,
pp. 475-484
Objectives: To model the economic impact of introducing an occupational vaccination programme for influenza with an inactivated influenza subunit vaccine (Influvac(R)) in the UK. Design and setting: Using published sources, a decision tree was constructed which modelled the costs and benefits of...
Persistent link: https://www.econbiz.de/10005448968
Saved in:
7
A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs
Gabriel, Sherine E.
;
Coyle, Douglas
;
Moreland, Larry W.
- In:
PharmacoEconomics
19
(
2001
)
7
,
pp. 715-728
and
cyclophosphamide
), sulfasalazine, methotrexate, leflunomide, cyclosporin, anti-tumour necrosis factor agents …
Persistent link: https://www.econbiz.de/10005448978
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
